UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (12) 12
science & technology (12) 12
humans (11) 11
female (9) 9
chemotherapy (8) 8
2nd-line treatment (6) 6
aged (6) 6
male (6) 6
oncology (6) 6
adult (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
docetaxel (5) 5
middle aged (5) 5
treatment outcome (5) 5
biological and medical sciences (4) 4
medical sciences (4) 4
neoplasm staging (4) 4
pharmacology & pharmacy (4) 4
umcg approved (4) 4
antineoplastic agents (3) 3
cancer (3) 3
carcinoma, non-small-cell lung - drug therapy (3) 3
disease-free survival (3) 3
lung neoplasms - drug therapy (3) 3
metastasis (3) 3
prognosis (3) 3
survival rate (3) 3
2nd-line chemotherapy (2) 2
abridged index medicus (2) 2
analysis (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
bevacizumab (2) 2
bevacizumab - therapeutic use (2) 2
breast cancer (2) 2
breast neoplasms - drug therapy (2) 2
breast neoplasms - pathology (2) 2
carcinoma, squamous cell - drug therapy (2) 2
care and treatment (2) 2
cisplatin (2) 2
colorectal neoplasms - drug therapy (2) 2
cost-benefit analysis (2) 2
double-blind (2) 2
erlotinib (2) 2
fluorouracil (2) 2
follow-up studies (2) 2
gemcitabine (2) 2
general & internal medicine (2) 2
growth-factor receptor (2) 2
health care sciences & services (2) 2
health policy & services (2) 2
irinotecan (2) 2
lung neoplasms - pathology (2) 2
medicine, general & internal (2) 2
metastatic breast cancer (2) 2
metastatic colorectal cancer (2) 2
neoplasm metastasis (2) 2
open-label (2) 2
oxaliplatin (2) 2
pharmacology. drug treatments (2) 2
quality of life (2) 2
research article (2) 2
respiratory system (2) 2
retreatment (2) 2
review (2) 2
second-line chemotherapy (2) 2
survival analysis (2) 2
taxoids - administration & dosage (2) 2
therapy (2) 2
tumors (2) 2
1506 (1) 1
1st-line treatment (1) 1
2nd line anti-tubercular therapy (1) 1
2nd line medications (1) 1
2nd-line (1) 1
2nd-line drugs (1) 1
2nd-line palliative chemotherapy (1) 1
2nd-line therapy (1) 1
3rd-line (1) 1
4500 (1) 1
5-fluorouracil (1) 1
5-fluorouracil plus leucovorin (1) 1
610 medicine & health (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - secondary (1) 1
adjuvant chemotherapy (1) 1
advanced esophagogastric cancer (1) 1
advanced gastric-cancer (1) 1
aged, 80 and over (1) 1
aids (1) 1
angiogenesis (1) 1
angiogenesis inhibitors - adverse effects (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
anti-egfr therapy; wild-type kras; factor receptor inhibitors; single-agent panitumumab; circulating tumor dna; plus irinotecan; 2nd-line treatment; phase-iii; acquired-resistance; ras mutations (1) 1
anti-inflammatory agents - therapeutic use (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antimetabolites, antineoplastic - adverse effects (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of thoracic oncology, ISSN 1556-0864, 04/2017, Volume 12, Issue 4, pp. 752 - 762
Journal Article
by Petrylak, Daniel P and de Wit, Ronald and Chi, Kim N and Drakaki, Alexandra and Sternberg, Cora N and Nishiyama, Hiroyuki and Castellano, Daniel and Hussain, Syed and Fléchon, Aude and Bamias, Aristotelis and Yu, Evan Y and van der Heijden, Michiel S and Matsubara, Nobuaki and Alekseev, Boris and Necchi, Andrea and Géczi, Lajos and Ou, Yen-Chuan and Coskun, Hasan Senol and Su, Wen-Pin and Hegemann, Miriam and Percent, Ivor J and Lee, Jae-Lyun and Tucci, Marcello and Semenov, Andrey and Laestadius, Fredrik and Peer, Avivit and Tortora, Giampaolo and Safina, Sufia and del Muro, Xavier Garcia and Rodriguez-Vida, Alejo and Cicin, Irfan and Harputluoglu, Hakan and Widau, Ryan C and Liepa, Astra M and Walgren, Richard A and Hamid, Oday and Zimmermann, Annamaria H and Bell-McGuinn, Katherine M and Powles, Thomas and Wong, Suet-Lai Shirley and Tan, Thean Hsiang and Hovey, Elizabeth Jane and Clay, Timothy Dudley and Ng, Siobhan Su Wan and Rutten, Annemie and Machiels, Jean-Pascal and Dumez, Herlinde and Cheng, Susanna Yee-Shan and Chi, Kim Nguyen and Ferrario, Cristiano and Sengeloev, Lisa and Jensen, Niels Viggo and Thibault, Constance and Laguerre, Brigitte and Laestadius, Fredrik and Joly, Florence and Flechon, Aude and Culine, Stéphane and Becht, Catherine and Niegisch, Günter and Stöckle, Michael and Grimm, Marc-Oliver and Gakis, Georgios and Schultze-Seemann, Wolfgang and Kalofonos, Haralambos and Mavroudis, Dimitrios and Papandreou, Christos and Karavasilis, Vasilis and Bamias, Aristotelis and Révész, Janos and Geczi, Lajos and Rosenbaum, Eli and Leibowitz-Amit, Raya and Kejzman, Daniel and Peer, Avivit and Sarid, David and Scagliotti, Giorgio Vittorio and Sternberg, Cora N and Tortora, Giampaolo and Bracarda, Sergio and Necchi, Andrea and Massari, Francesco and Osawa, Takahiro and Miyajima, Naoto and Shinohara, Nobuo and Fukuta, Fumimasa and Ohyama, Chikara and Obara, Wataru and Yamashita, Shinichi and Tomita, Yoshihiko and Kawai, Koji and Fukasawa, Satoshi and Matsubara, Nobuaki and Oyama, Masafumi and Yonese, Junji and Nagata, Masayoshi and Uemura, Motohide and Nishimura, Kazuo and Kawakita, Mutsushi and Tsunemori, Hiroyuki and ... and RANGE study investigators and RANGE Study Investigators
The Lancet (British edition), ISSN 0140-6736, 11/2017, Volume 390, Issue 10109, pp. 2266 - 2277
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2009, Volume 27, Issue 12, pp. 2038 - 2045
RHEUMATOID-ARTHRITIS | TRIAL | POLYMORPHISMS | CISPLATIN | METHYLENETETRAHYDROFOLATE REDUCTASE GENE | 2ND-LINE TREATMENT | METHOTREXATE | DOCETAXEL | UMCG Approved | THYMIDYLATE-SYNTHASE | CHEMOTHERAPY | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Tumors | Pneumology | Carcinoma, Large Cell - drug therapy | Lung Neoplasms - drug therapy | Prognosis | Follow-Up Studies | Guanine - analogs & derivatives | Carcinoma, Squamous Cell - genetics | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Methylenetetrahydrofolate Reductase (NADPH2) - genetics | Membrane Transport Proteins - genetics | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Carcinoma, Large Cell - genetics | gamma-Glutamyl Hydrolase - genetics | Lung Neoplasms - genetics | Pharmacogenetics | Carcinoma, Non-Small-Cell Lung - genetics | Risk Factors | Carboplatin - administration & dosage | Survival Rate | Treatment Outcome | Adenocarcinoma - drug therapy | Pemetrexed | Thymidylate Synthase - genetics | Adenocarcinoma - secondary | Disease Progression | Reduced Folate Carrier Protein | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Glutamates - administration & dosage | Carcinoma, Squamous Cell - secondary | Polymorphism, Genetic - genetics | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Guanine - administration & dosage | Index Medicus
Journal Article
Journal Article
Journal Article